A recent meta-analysis including 2717 participants (799 with Crohn’s disease, 520 with ulcerative colitis, and 609 healthy controls) demonstrated that circulating chemerin levels are significantly elevated in inflammatory bowel disease, especially during active phases. This evidence concerns the gene RARRES2 and Crohn disease.